Treatment.com AI Inc. (CSE:TRUE)

Treatment.com AI Income Statement

Financials in millions CAD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Sep 30, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Cost of Revenue	0.01	0.38	0.66	0.33	-	-
Gross Profit	0.02	-0.38	-0.66	-0.33	-	-
Selling, General & Admin	1.65	1.39	4.06	0.82	0.35	0.05
Research & Development	0.01	0.59	2.19	1.3	0.33	0.02
Operating Expenses	1.96	3.41	13.24	2.58	0.67	0.07
Operating Income	-1.94	-3.79	-13.9	-2.91	-0.67	-0.07
Interest Expense	-0.09	-0.05	-	-	-	-
Currency Exchange Gain (Loss)	-0	-0.01	-0.03	-	-	-
Other Non Operating Income (Expenses)	-0.01	-0.01	0.01	-	-	-
EBT Excluding Unusual Items	-2.04	-3.86	-13.91	-2.91	-0.67	-0.07
Other Unusual Items	0.03	0.07	0.05	-	-2.33	-
Pretax Income	-2.01	-3.8	-13.86	-2.91	-3	-0.07
Net Income	-2.01	-3.8	-13.86	-2.91	-3	-0.07
Net Income to Common	-2.01	-3.8	-13.86	-2.91	-3	-0.07
Shares Outstanding (Basic)	12	7	6	6	3	2
Shares Outstanding (Diluted)	12	7	6	6	3	2
Shares Change (YoY)	78.95%	2.08%	13.46%	78.23%	51.64%	1.06%
EPS (Basic)	-0.17	-0.57	-2.14	-0.51	-0.94	-0.03
EPS (Diluted)	-0.17	-0.57	-2.14	-0.51	-0.94	-0.03
EBIT	-1.94	-3.79	-13.9	-2.91	-0.67	-0.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.